chrisvoncsefalvay/vaers-outcomes huggingface dataset:
losing her taste a little bit/loss of taste was slight/loss of taste was subtle; losing her smell a little bit; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (losing her taste a little bit/loss of taste was slight/loss of taste was subtle) and ANOSMIA (losing her smell a little bit) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 041B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 20-Nov-2020, Gastric disorder (Unknown stomach issues) and Scalp disorder (unknown scalp issues). Concurrent medical conditions included Hypothyroidism (diagnosed 30 years ago), Allergic reaction to analgesics (Allergy to Ibuprofen (causes rash on chest)) and Drug allergy (Allergy to Claritin (increases heart rate and causes anxiety).). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced AGEUSIA (losing her taste a little bit/loss of taste was slight/loss of taste was subtle) and ANOSMIA (losing her smell a little bit). At the time of the report, AGEUSIA (losing her taste a little bit/loss of taste was slight/loss of taste was subtle) and ANOSMIA (losing her smell a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported
Significant swelling and redness at injection sight on day 8 following vaccination. Site is additionally extremely itchy.
Urticaria & swelling at injection site spreading down to forearm. Given Benadryl and rash resolved.
I had a stroke in March of 2022. I couldn?t talk correctly/formulate words, right arm numbness and weakness,  right leg weakness, & drooling without knowledge
Information has been received from a health professional concerning "an unknown number of patient's" who in 2007 were vaccinated with pneumococcal 23v polysaccharide vaccine (Lot # not reported) and developed cellulitis at the injection site. There were no patient specifics provided. A few of the patients my have received the influenza virus vaccine (unspecified) concomitantly. The reporter did not know if the pneumococcal 23v polysaccharide vaccine was the first or second for the patients. The patients sought unspecified medical attention. On an unspecified date, the patients recovered from the injection site cellulitis. No additional information was provided. Additional information has been requested.
Patient administered vaccine past the expiration date on 09-May-2022, expiration date: 03-Apr-2022; Patient administered vaccine past the expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Patient administered vaccine past the expiration date on 09-May-2022, expiration date: 03-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine past the expiration date) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine past the expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient administered vaccine past the expiration date on 09-May-2022, expiration date: 03-Apr-2022). At the time of the report, PRODUCT STORAGE ERROR (Patient administered vaccine past the expiration date on 09-May-2022, expiration date: 03-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine past the expiration date) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The provider removed the vaccine from the fridge thawed whether needed, and administered the same day of removal.   A total 15 doses were administered.  The date of the vial removed from the fridge was 09-May-2022.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2022: Follow-up document received includes significant information; lot number of suspect vaccine was updated.
No adverse event; PROQUAD was administered to a 17 year old patient .; This spontaneous report was received from Other Health Professional and refers to a 17-year-old patient.  Information regarding the patient's concurrent conditions, medical history, historical drugs and concomitant therapies was not provided.  On an unknown date, the patient was vaccinated with 1 dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, lot #W029547, expiration date: 14-MAR-2024, administered for prophylaxis (strength, and route of administration were not provided) (Product administered to patient of inappropriate age). No other adverse event. No product quality complaint.
Information has been received from a physician and a nurse concerning a patient who on an unspecified date was vaccinated with standard dose injection of PNEUMOVAX 23 (lot number not reported). Subsequently the patient developed a local site reaction and experienced a lot of pain and redness on the injection site. Unspecified medical attention was ought. On an unspecified date the patient recovered. Additional information has been requested.
Patient felt dizzy and light-headed shortly after immunizations. After 5 minutes, he began throwing up. After an additional 2 minutes, he began breathing quickly and deeply. At this time he stated feeling short of breath.
Administered vaccine, and syringe separated from needle during administration. Given full dose after missed dose.
The decedent?s husband, reports that the decedent has been suffering abdominal pains regularly for several years, but claims they usually pass on their own. This morning, the decedent?s pain wouldn?t pass, and Mr. called 911 at approximately 1200hrs. Hospital staff reports decedent came to the ED at 1300hrs on 10/12/21 complaining of severe abdominal pains. CT scans were unremarkable and decedent was admitted for observation. At 2250hrs this evening, the decedent began to vomit water, began labored breathing, and and became unresponsive. Decedent coded, and hospital staff performed CPR and ALCS, but were unable to resuscitate. Death was pronounced by Dr., at 2315hrs.
Estimated date of delivery is 9/14/22.  I developed a sore throat, congestion, dry cough, extreme fatigue, chills, shortness of breath and brain fog on 7/25.  I tested positive for COVID-19 on 7/26.  I contacted my doctor on 7/27.  They advised me a over-the-counter medications I could take.  I have taken Tylenol, Mucinex and Nasalpro.
Sore arm approximately 24 hours in duration; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 19Mar2021 at 16:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021 at 16:00, the patient experienced sore arm approximately 24 hours in duration. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of sore arm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm approximately 24 hours in duration was recovered on 20Mar2021. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on an unknown date in 2021, as a single dose for COVID-19 immunisation.  No follow-up attempts are possible. No further information is expected.
described his experience as severe debilitating back ache; inability to bend; This is a spontaneous report from a contactable consumer or other non hcp. A 46-years-old male patient received bnt162b2 (BNT162B2; Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021(at the age of 46 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was unknown, if the patient had covid prior vaccination, if covid tested post vaccination, other medical history. The patient experienced described his experience as severe debilitating back ache on an unspecified date, inability to bend on an unspecified date. Therapeutic measures were taken as a result of events as, the patient says he took Advil. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Pain and itching all over body. Especially in the feet, arms, legs and hands. Same thing happened to me after my second dosage. Except back in October 2021 I ended up in the hospital five days later. Now I am experiencing that same pain, but unfortunately at this point in the middle of a job transition there is a lapse in my insurance.
Case number PHEH2012US006267 is an initial spontaneous report received from a consumer on 16 Mar 2012. This report refers to a patient of unspecified age and gender. Medical history, past drugs, current conditions and concomitant medications were not reported. The patient was vaccinated with H1N1 (manufacturer and batch number: unspecified) 0.5 ml dose, intramuscularly on an unspecified date. After vaccination, the patient had issues with the nerves in ears (onset date unspecified). Final event outcome was not reported. No further information was available.
Atypical screaming for 4-5 hours, no appetite for 17 hours, urinated only twice in 20 hours, severe limpness of arms and legs (child moved shoulders, but could not raise arms.  Arms hung limp at sides of body).
(L) arm deltoid pain and shoulder pain x 2 days starting 14 days after injection. No erythema, no ecchymosis, no induration, no warmth at injection site. Tx -warm packs, ROM exercises, Tylenol/Aleve.
When I was given the shot my body went into a severe shaking uncontrollable for an hour and then other problems began by May all of these problems began -muscle pain. cognitive problems, heart palpitation, hot flashes, wobbly with my legs and couldn't walk felt like a puppet trying to pick up something from the floor, tinging in my hands, My nails cracked and Hair started falling. Since getting the virus in June 2022 some of these systems began to disappear like the fogginess feel better. Test for auto immune have increase. My finger have developed Arthritis. I felt my whole body was being attacked .I developed Seborrheic Dermatitis.
Information has been received from a consumer concerning her son with no past medical history who at 16 month old in approx. 3/98 was vaccinated with MMRII. There were no concomitant medication. It was reported that her son has "autistic tendencies". It was also noted that her son was not very verbal to begin with and after he was vaccinated, he stopped speaking. Upon internal review, "autistic tendencies" was determined to be an "Other Important Medical Event". Additional information has been requested.
Headaches and body aches a couple of hours after the shot, then throughout the next day, but bearable. Then just over 24 hours after the shot those symptoms worsened and I developed chills with a fever at 100.8. That lasted about 1-2 hours, then the fever broke before I went to bed. Second day after the shot now and I have some lingering soreness with a little bit of a headache, but nothing really significant.
Right shoulder pain with movement. Limited range of motion. Tenderness at site of injection. No redness, swelling, induration. ADVIL and ALEVE not effective. Prednisone x 7 days temporary improvement. Currently, ongoing discomfort with movement. Mild tingling down arm.
Discharge Provider: MD Primary Care Provider at Discharge: DNP, A-GNP Admission Date: 5/12/2022 Discharge Date: 5/14/2022  PRESENTING PROBLEM: Acute kidney injury due to COVID-19 (HCC) COVID-19      HPI: 85-year-old female with a history of hypertension, hyperlipidemia, previous CVA with left-sided weakness, chronic kidney disease stage 3. Patient presents to the emergency room with complaints of weakness for over a month.  Much worse over the last week.  Last night she had a cough which would not allow her to sleep, nonproductive.  She denies any fevers or chills.  No chest pain.  She does states she has been short of breath for the last week or 2, particularly with exertion.  Patient presented to the emergency room today as her cough was worsening.  On arrival she was hemodynamically stable, satting 97% on room air.  She was mildly ill appearing but pleasant and conversant.  Lungs show diminished breath sounds at the bases heart was regular rate and rhythm abdomen was benign.  Extremities showed 1+ edema with chronic venous stasis changes bilaterally. Sodium 138 potassium 5.1 chloride 110 CO2 16 BUN 72 creatinine 2.16 (baseline creatinine is around 1.3).  Glucose 152 liver enzymes normal complete blood count was normal.  Chest x-ray showed no acute disease. Patient has COVID-19 came back positive. Patient states she has had slight decreased oral intake over the last week.  She denies taking NSAIDs.  Patient also has a chronic ileostomy, history of Crohn's disease.  Currently not on medications.     HOSPITAL COURSE: Patient did well.  She was gently hydrated with IV fluids and her acute kidney injury continue to improve, creatinine now 1.4.  She was eating well, having reasonable urine output.  Vital signs have been stable.  She has been on room air oxygen throughout this admission, not showing any signs or symptoms of COVID-19 pneumonia.  Patient is stable for discharge.  On day of discharge she reports that she feels stronger today than she has in over a month.  Patient will continue with COVID 19 discharge instructions, also encourage good oral intake.  Patient to follow-up with primary care provider next week.  Patient does have a mild persistent metabolic acidosis, which can be followed up as outpatient with repeat BMP next week.  Patient advised to return should she develop any shortness of breath or any other problems
Redness; Arm soreness; This case was reported by a consumer and described the occurrence of erythema in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced erythema and pain in arm. On an unknown date, the outcome of the erythema and pain in arm were unknown.   It was unknown if the reporter considered the erythema and pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient had redness and arm soreness after vaccination. Limited demographics and information gathered, due to caller rushing to end phone call. The repoter did not consented to follow up.
Tingling and stiffness on the side I received the shot; Tingling and stiffness on the side I received the shot/limb stiffness; I'm also still having headaches,  to the point I have to take advil (Tylenol was not helping).; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01May2021 16:15 (Lot number: Ew0171) at the age of 35 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: Ew0153, Administration time: 10:00, route of administration: unspecified ), administration date: 10Apr2021, when the patient was 35 years old, for COVID-19 immunisation. The following information was reported: PARAESTHESIA (non-serious) with onset 02May2021, outcome "not recovered", described as "Tingling and stiffness on the side I received the shot"; MUSCULOSKELETAL STIFFNESS (non-serious) with onset 02May2021, outcome "not recovered", described as "Tingling and stiffness on the side I received the shot/limb stiffness"; HEADACHE (non-serious) with onset 02May2021, outcome "not recovered", described as "I'm also still having headaches, to the point I have to take advil (Tylenol was not helping).". Therapeutic measures were not taken as a result of paraesthesia, musculoskeletal stiffness. Therapeutic measures were taken as a result of headache.  Additional information: The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 the patient experienced tingling and stiffness on the side she received the shot. She received the shot in left arm, and had issues in both that arm and leg. The tingling was subsiding in arm. Leg, the tingling and stiffness had subsided below the knee, but still felt it above. She was more uncomfortable than in pain from these issues. Also still having headaches. Patient received ADVIL for headache as TYLENOL was not helping. She also reported that, she may need to contact her doctor soon if this doesn't resolve itself. It had been days at that point. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.   No follow-up attempts are possible. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP) from product quality group. The reporter is the patient.  A 71-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 17:00 as dose 4 (booster), single (Lot number: G56665) at the age of 71 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "CLL" (unspecified if ongoing), notes: Other medical history: CLL; "Parkinson's disease" (unspecified if ongoing), notes: Other medical history: Parkinson's disease. Concomitant medication(s) included: ATORVASTATIN, start date: 01Nov2018, stop date: 01Nov2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Nov2022) Negative, notes: Antigen test negative 07Nov and 09Nov2022; (09Nov2022) Negative, notes: Antigen test negative 07Nov and 09Nov2022. Therapeutic measures were taken as a result of covid-19.; Sender's Comments: The efficacy of a vaccine varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine product BNT162B2 to the reported events drug ineffective and COVID-19 cannot be ruled out.
About 2 weeks following the 1st dose of the shot, I began experiencing abnormal menstrual bleeding.  After the 2nd dose, it became worse. The bleeding became extremely heavy, did not stop and did not respond to progesterone.  Solution to problem was hysterectomy 9/2/2021. It is unknown whether there will be additional adverse events.
Arm hurts; Bad bruise; It just rubs; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm hurts), CONTUSION (Bad bruise) and PRURITUS (It just rubs) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009021A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced MYALGIA (Arm hurts), CONTUSION (Bad bruise) and PRURITUS (It just rubs). At the time of the report, MYALGIA (Arm hurts), CONTUSION (Bad bruise) and PRURITUS (It just rubs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.
After 2nd shot my arm was very painful; reddish oval continued to grow larger each day, till it is now (2/19) around 6 inches inlength; This is a spontaneous report from a contactable consumer(patient). A 73-year-old female (non-pregnant) patient received second dose of BNT162B2 (Solution for injection, Lot number: EL9264, Expiration date: unknown), in left arm on 15Feb2021at 01:45 PM at single dose for COVID-19 immunization. The patient historical vaccine included first dose BNT162B2 (lot number: EN5318) left arm on 25Jan2021, 03:30 PM at single Covid-19 immunization. The patient medical history included bullous Pemphigoid in remission. Concomitant medication included in two weeks Generic Prozac & Lipitor, Fish Oil, Biotin, Iron. Patient was having known allergies to titanium, dark dye, some chemicals found in cosmetics. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. After second shot Patient experienced her arm was very painful in morning after there was a small, hot reddish oval that was painful, that hot, reddish oval continued to grow larger each day, till it is now (2/19) around 6 inches in length on 16Feb2021 at 12:00 AM. The part near the injection site is much less red but the rest of the oval is still reddish. It's still hot & sore to touch but it was not as painful as it was through Wednesday. The outcome of the event was not recovered.
1. Patient had sudden bilateral thigh rash ( vasculitic like, bright red, softball sized) that she noticed 2 hours after vaccination, and lasted for another 3 hours then went away without intervention.   2. Patient had shingles flare on Left Maxillary branch, starting 2 days after (1/10/2021). She took acyclovir for one week (800mg five times daily). After four days of completing this antiviral course, she had a left mandibular distribution of shingles sensation, was placed on a week of valacyclovir 1 gm TID.